Netakimab
- Generic Name
- Netakimab
Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children with Moderate to Severe Plaque Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2024-10-14
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Biocad
- Target Recruit Count
- 140
- Registration Number
- NCT06640517
- Locations
- π·πΊ
Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation
π·πΊState budgetary healthcare institution "Chelyabinsk Regional Clinical Dermatovenerological Dispensary", Chelyabinsk, Russian Federation
π·πΊState budgetary institution of the Sverdlovsk region "Ural Research Institute of Dermatovenereology and Immunopathology", Ekaterinburg, Russian Federation
COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU
- Conditions
- COVID-19Mild to Moderate
- Interventions
- Other: Standard of care therapy
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Pirogov Russian National Research Medical University
- Target Recruit Count
- 154
- Registration Number
- NCT05302947
- Locations
- π·πΊ
Pirogov Russian National Research Medical University, Moscow, Russian Federation
π·πΊCity Clinical Hospital No. 52 of the Department of Health of the City of Moscow, Moscow, Russian Federation
Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Biocad
- Target Recruit Count
- 194
- Registration Number
- NCT03598751
- Locations
- π§πΎ
1st City Clinical Hospital, Minsk, Belarus
π·πΊNorth-Western State Medical University n.a. I.I.Mechnikov, Saint-Petersburg, Russian Federation
π·πΊChelyabinsk Regional Clinical hospital, Chelyabinsk, Russian Federation
International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis
- Conditions
- Ankylosing Spondylitis
- Interventions
- Other: placebo
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Biocad
- Target Recruit Count
- 228
- Registration Number
- NCT03447704
- Locations
- π·πΊ
Non-governmental Healthcare Institution "Railway Clinical hospital on the Chelyabinsk Station of JSC Russian Railways", Chelyabinsk, Russian Federation
π·πΊLLC BioEk, Saint-Petersburg, Russian Federation
π·πΊKazan State Medical University, Kazan, Russian Federation
Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Biocad
- Target Recruit Count
- 88
- Registration Number
- NCT02763111
International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Biocad
- Target Recruit Count
- 120
- Registration Number
- NCT02762994
- Locations
- π·πΊ
BIOCAD, Saint Petersburg, Strelna, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.